bacterial lung infections

After buying in candidate, Mannkind wraps up phase 1 trial of inhaled lung infection prospect
Fierce Pharma
Tue, 09/6/22 - 12:04 pm
MannKind
clofazimine
FDA
bacterial lung infections
clinical trials